Morales-Medina J. C., Juarez I., Venancio-Garcia E., Cabrera S. N., Menard C., Yu W., Flores G., Mechawar N., Quirion R. (2013). Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat, Neuroscience. Find out more.

Nazeri A., Chakravarty M., Felsky D., Lobaugh N. J., Rajji T. K., Mulsant B. H., Voineskos A. N. (2013). Alterations of superficial white matter in schizophrenia and relationship to cognitive performance, Neuropsychopharmacology, 38(10), 1954-62. Find out more.

Palmour N., Vanderbyl B. L., Zimmerman E., Gauthier S., Racine E. (2013). Alzheimer's Disease Dietary Supplements in Websites, HEC Forum. Find out more.

Papadopoulos P., Rosa-Neto P., Rochford J., Hamel E. (2013). Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-beta and cerebrovascular pathology, PLoS One, 8(7), e68612. Find out more.

Parent M. J., Bedard M. A., Aliaga A., Minuzzi L., Mechawar N., Soucy J. P., Schirrmacher E., Kostikov A., Gauthier S., Rosa-Neto P. (2013). Cholinergic Depletion in Alzheimer's Disease Shown by [(18) F]FEOBV Autoradiography, Int J Mol Imaging, 2013, 205045. Find out more.

Parent M. J., Cyr M., Aliaga A., Kostikov A., Schirrmacher E., Soucy J. P., Mechawar N., Rosa-Neto P., Bedard M. A. (2013). Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry, EJNMMI Res, 3(1), 70. Find out more.

Patterson C., Gauthier S. (2013). Diagnosis and treatment of dementia: the fourth canadian consensus conference, Alzheimers Res Ther, 5(Suppl 1), S1. Find out more.

Peters M. E., Rosenberg P. B., Steinberg M., Norton M. C., Welsh-Bohmer K. A., Hayden K. M., Breitner J., Tschanz J. T., Lyketsos C. G., Cache County Investigators (2013). Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study, Am J Geriatr Psychiatry, 21(11), 1116-24. Find out more.

Poirier J., Gauthier S. (2013). Ich habe mich selbst verloren, .

Pruessner M., Bechard-Evans L., Boekestyn L., Iyer S.N., Pruessner J., Malla A. (2013). Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis, Schizophr Res, 146(1-3), 79-86. Find out more.

Pruessner M., Vracotas N., Joober R., Pruessner J., Malla A. (2013). Blunted cortisol awakening response in men with first episode psychosis: relationship to parental bonding, Psychoneuroendocrinology, 38(2), 229-40. Find out more.

Quirion R., Brière R. (2013). Génomique, épigénomique et troubles de santé mentale, , 3, 11-15.

Reckess G. Z., Brandt J., Luis C. A., Zandi P., Martin B., Breitner J. (2013). Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial, J Alzheimers Dis, 36(3), 433-43. Find out more.

Rive B., Gauthier S., Costello S., Marre C., Francois C. (2013). Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease, CNS Drugs, 27(7), 573-82. Find out more.

Rosa-Neto P., Hsiung G. Y., Masellis M. (2013). Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians, Alzheimers Res Ther, 5(Suppl 1), S8. Find out more.

Rowley J., Fonov V., Wu O., Eskildsen S. F., Schoemaker D., Wu L., Mohades S., Shin M., Sziklas V., Cheewakriengkrai L., Shmuel A., Dagher A., Gauthier S., Rosa-Neto P., Alzheimer's Disease Neuroimaging Initiative (2013). White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease, PLoS One, 8(9), e74776. Find out more.

Schilling L. P., Kieling R. R., Pascoal T. A., Kim H. I., Lee M. C., Kim Y. H., Paglioli E., Rosa-Neto P., Costa J. C., Palmini A. (2013). Bilateral perisylvian ulegyria: an under-recognized, surgically remediable epileptic syndrome, Epilepsia, 54(8), 1360-7. Find out more.

Schwabe L., Nader K., Pruessner J. (2013). beta-Adrenergic blockade during reactivation reduces the subjective feeling of remembering associated with emotional episodic memories, Biol Psychol, 92(2), 227-32. Find out more.

Seifert C. L., Chakravarty M., Sprenger T. (2013). The complexities of pain after stroke--a review with a focus on central post-stroke pain, Panminerva Med, 55(1), 1-10. Find out more.

Shukla M., Quirion R., Ma W. (2013). Reduced expression of pain mediators and pain sensitivity in amyloid precursor protein over-expressing CRND8 transgenic mice, Neuroscience. Find out more.